Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1270205 | 0.92 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CMAPTKDM4E | |
| SCHEMBL20044956 | 0.92 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CMAPTKDM4E | |
| SCHEMBL29360481 | 0.92 | CACNA2D1 (0.37) | CACNA2D1CACNB2CACNA1CMAPTNQO2 | |
| SCHEMBL336442 | 0.92 | CACNA2D1 (0.37) | CACNA2D1CACNB2CACNA1CMAPTNQO2 | |
| SCHEMBL18267813 | 0.90 | CACNA2D1 (0.36) | CACNA2D1CACNB2CACNA1CMAPTKDM4E | |
| SCHEMBL651091 | 0.89 | CACNA2D1 (0.33) | CACNA2D1CACNB2CACNA1CKDM4ELMNA | |
| SCHEMBL30360377 | 0.89 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CMAPTKDM4E | |
| SCHEMBL14514097 | 0.89 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CMAPTKDM4E | |
| SCHEMBL2161848 | 0.86 | ESR1 (0.35) | CACNA2D1CACNB2CACNA1CKDM4ELMNA | |
| SCHEMBL27725041 | 0.85 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1880429-B1 | POLYACENE AND SEMICONDUCTOR FORMULATION | MERCK PATENT GMBH (DE) | 2012-06-27 | — | — | EP | disclosed |
| US-7935960-B2 | organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances | MERCK PATENT GMBH (DE) | 2011-05-03 | — | — | US | disclosed |
| US-7935960-B2 | organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances | MERCK PATENT GMBH (DE) | 2011-05-03 | — | — | US | disclosed |
| US-7935960-B2 | organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances | MERCK PATENT GMBH (DE) | 2011-05-03 | — | — | US | disclosed |
| US-20100308304-A1 | ELECTRONIC SHORT CHANNEL DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR FORMULATION | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-09 | — | — | US | disclosed |
| EP-1986247-A1 | Polyacene and semiconductor Formulation | MERCK PATENT GmbH (DE) | 2008-10-29 | — | — | EP | disclosed |
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| EP-1880429-A1 | POLYACENE AND SEMICONDUCTOR FORMULATION | Merck Patent GmbH (DE) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006119853-A1 | POLYACENE AND SEMICONDUCTOR FORMULATION | MERCK PATENT GMBH (DE) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | OR51E2, PIEZO1, FDFT1 | CACNA2D1 1110/4885CACNB2 1262/4885CACNA1C 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.